Hyperparathyroidism is an increased parathyroid hormone (PTH) levels in the blood. This occurs either from the parathyroid glands inappropriately making too much PTH (primary hyperparathyroidism) or other events triggering increased production by the parathyroid glands (secondary hyperparathyroidism). Most people with primary disease have no symptoms at the time of diagnosis. In those with symptoms the most common is kidney stones with other potential symptoms including weakness, depression, bone pains, confusion, and increased urination. Both types increase the risk of weak bones. Primary hyperparathyroidism in 80% of cases is due to a single benign tumor known as a parathyroid adenoma with most of the rest of the cases due to a multiple benign tumors.
Organism species: Pan-species (General)
|PRODUCT TYPE||CATALOG NO.||PRODUCT NAME||APPLICATIONS|
|Proteins||N/A||Recombinant Hyperparathyroidism (HP)||Antigenic Transformation Customized Service Offer|
|Antibodies||N/A||Monoclonal Antibody to Hyperparathyroidism (HP)||Monoclonal Antibody Customized Service Offer|
|N/A||Polyclonal Antibody to Hyperparathyroidism (HP)||Polyclonal Antibody Customized Service Offer|
|Assay Kits||N/A||CLIA Kit for Hyperparathyroidism (HP)||CLIA Kit Customized Service Offer|
|N/A||ELISA Kit for Hyperparathyroidism (HP)||ELISA Kit Customized Service Offer|